Neal S. Walker D.O.
Net Worth

Last updated:

What is Neal S. Walker D.O. net worth?

The estimated net worth of Dr. Neal S. Walker D.O. is at least $15,201,114 as of 4 Dec 2024. He owns shares worth $2,228,104 as insider, has earned $5,381,240 from insider trading and has received compensation worth at least $7,591,770 in Aclaris Therapeutics, Inc..

What is the salary of Neal S. Walker D.O.?

Dr. Neal S. Walker D.O. salary is $843,530 per year as Co-Founder, Chief Executive Officer, Pres & Director in Aclaris Therapeutics, Inc..

How old is Neal S. Walker D.O.?

Dr. Neal S. Walker D.O. is 55 years old, born in 1970.

What stocks does Neal S. Walker D.O. currently own?

As insider, Dr. Neal S. Walker D.O. owns shares in one company:

Company Title Shares Price per share Total value
Aclaris Therapeutics, Inc. (ACRS) Co-Founder, Chief Executive Officer, Pres & Director 1,273,202 $1.75 $2,228,104

What does Aclaris Therapeutics, Inc. do?

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

ACRS logo
ACRS
Aclaris Therapeutics, Inc.
$1.75

Neal S. Walker D.O. insider trading

Aclaris Therapeutics, Inc.

Dr. Neal S. Walker D.O. has made 18 insider trades between 2016-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 148,714 units of ACRS stock on 2 Mar 2020. As of 4 Dec 2024 he still owns at least 1,273,202 units of ACRS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Option (right to buy) 118,840 $1.52 $180,637
Option
Common Stock 118,840 $1.52 $180,637
Option
Restricted Stock Units 9,466 N/A N/A
Option
Common Stock 9,466 N/A N/A
Option
Restricted Stock Units 9,467 N/A N/A
Option
Common Stock 9,467 N/A N/A
Option
Restricted Stock Units 9,467 N/A N/A
Option
Common Stock 9,467 N/A N/A
Option
Common Stock 9,466 N/A N/A
Option
Restricted Stock Units 9,466 N/A N/A
Option
Employee Stock Option (right to buy) 43,548 $0.72 $31,355
Option
Common Stock 43,548 $0.72 $31,355
Option
Common Stock 9,467 N/A N/A
Option
Restricted Stock Units 9,467 N/A N/A
Option
Common Stock 9,467 N/A N/A
Option
Restricted Stock Units 9,467 N/A N/A
Option
Restricted Stock Units 9,466 N/A N/A
Option
Common Stock 9,466 N/A N/A
Option
Restricted Stock Units 9,467 N/A N/A
Option
Common Stock 9,467 N/A N/A
Option
Restricted Stock Units 9,467 N/A N/A
Option
Common Stock 9,467 N/A N/A
Option
Restricted Stock Units 9,466 N/A N/A
Option
Common Stock 9,466 N/A N/A
Sale
Common Stock 30,240 $12.64 $382,082
Option
Common Stock 18,254 N/A N/A
Sale
Common Stock 29,000 $12.37 $358,585
Option
Restricted Stock Units 18,254 N/A N/A
Option
Common Stock 24,000 N/A N/A
Option
Restricted Stock Units 96,150 N/A N/A
Option
Common Stock 96,150 N/A N/A
Option
Restricted Stock Units 18,275 N/A N/A
Option
Common Stock 18,275 N/A N/A
Option
Restricted Stock Units 24,000 N/A N/A
Sale
Common Stock 200 $17.54 $3,507
Sale
Common Stock 3,121 $16.88 $52,692
Sale
Common Stock 600 $15.55 $9,332
Sale
Common Stock 1,079 $14.57 $15,718
Sale
Common Stock 25,000 $16.75 $418,675
Sale
Common Stock 15,000 $14.89 $223,350
Sale
Common Stock 1,618 $16.16 $26,145
Sale
Common Stock 23,382 $15.19 $355,079
Sale
Common Stock 20,000 $15.18 $303,660
Sale
Common Stock 25,000 $15.04 $376,100
Sale
Common Stock 25,000 $15.24 $380,950
Sale
Common Stock 56,303 $15.92 $896,062
Option
Restricted stock units 96,150 N/A N/A
Option
Restricted stock units 18,275 N/A N/A
Option
Common Stock 18,254 N/A N/A
Option
Restricted stock units 18,254 N/A N/A
Option
Common Stock 18,275 N/A N/A
Option
Common Stock 96,150 N/A N/A
Sale
Common Stock 3,595 $12.66 $45,513
Option
Restricted Stock Units 10,800 N/A N/A
Option
Common Stock 10,800 N/A N/A
Sale
Common Stock 33,260 N/A N/A
Sale
Common Stock 33,260 $21.91 $728,560
Option
Restricted Stock Units 73,015 N/A N/A
Option
Common Stock 73,015 N/A N/A
Sale
Common Stock 30,000 $26.84 $805,230
Option
Common Stock 18,253 N/A N/A
Option
Restricted stock units 18,253 N/A N/A
Option
Common Stock 96,150 N/A N/A
Option
Restricted stock units 96,150 N/A N/A
Option
Common Stock 10,800 N/A N/A
Option
Restricted Stock Units 10,800 N/A N/A
Option
Restricted Stock Units 3,034 N/A N/A
Option
Common Stock 3,034 N/A N/A
Option
Common Stock 83,092 N/A N/A
Option
Restricted stock units 83,092 N/A N/A
Option
Common Stock 73,014 N/A N/A
Option
Restricted stock units 73,014 N/A N/A
Option
Common Stock 148,714 $0.63 $93,690
Option
Restricted stock units 148,714 $0.63 $93,690
Option
Restricted Stock Units 10,800 N/A N/A
Option
Common Stock 10,800 N/A N/A
Option
Restricted Stock Units 2,925 N/A N/A
Option
Common Stock 2,925 N/A N/A
Option
Common Stock 3,033 N/A N/A
Option
Restricted Stock Units 3,033 N/A N/A
Option
Common Stock 10,800 N/A N/A
Option
Restricted Stock Units 10,800 N/A N/A
Option
Restricted Stock Units 2,925 N/A N/A
Option
Common Stock 2,925 N/A N/A
Option
Common Stock 3,033 N/A N/A
Option
Restricted Stock Units 3,033 N/A N/A
Option
Common Stock 12,133 N/A N/A
Option
Restricted Stock Units 12,133 N/A N/A
Purchase
Common Stock 10,000 $16.75 $167,500
Option
Restricted Stock Units 2,925 N/A N/A
Option
Common Stock 2,925 N/A N/A
Option
Common Stock 3,033 N/A N/A
Option
Restricted Stock Units 3,033 N/A N/A
Option
Restricted Stock Units 2,925 N/A N/A
Option
Common Stock 2,925 N/A N/A

Aclaris Therapeutics key executives

Aclaris Therapeutics, Inc. executives and other stock owners filed with the SEC: